The office, the factory floor, the hospital ward, the classroom — these are the places where medical cannabis policy meets lived reality. And right now, the meeting is not going smoothly.
UK employment law provides some protections for prescribed patients. It also leaves significant gaps that employers and employees are navigating case by case, often badly.
The Legal Framework
The Equality Act 2010 protects employees from discrimination on the basis of disability. If your condition — chronic pain, anxiety, PTSD, multiple sclerosis, or any of the other conditions for which cannabis is prescribed — meets the legal definition of disability, your employer has a duty to make reasonable adjustments.
A reasonable adjustment could include allowing you to take prescribed medication during working hours, modifying your duties if your medication affects your ability to perform certain tasks, or — most relevantly for cannabis patients — adjusting the company's drugs policy to accommodate prescribed controlled drugs.
The key legal question, which no UK employment tribunal has yet definitively answered, is whether a blanket zero-tolerance drugs policy that makes no exception for prescribed cannabis constitutes indirect disability discrimination. Legal opinion leans toward yes — but opinion is not precedent, and until a case reaches a tribunal, patients operate in a legal grey zone.
To Disclose or Not to Disclose
This is the hardest decision most employed patients face. Disclosing your prescription to your employer carries risks: stigma, differential treatment, and in the worst case, dismissal. Not disclosing carries different risks: if you are drug-tested and the result is positive, you have no pre-existing defence to a disciplinary process.
The balance depends on your employer, your role, and your relationship with your line manager. In safety-critical roles — driving, operating machinery, clinical care — disclosure is almost certainly the safer course. Your employer needs to know about any medication that could affect your fitness to work, and you need the protection of having disclosed it in advance.
In office-based roles where your medication is taken outside working hours and does not affect your performance, the calculus is different. Many patients in these roles choose not to disclose and have done so without incident for years. The risk is a sudden policy change, a random drug test, or a manager who discovers the prescription and reacts badly.
Practical Steps for Disclosing
If you decide to disclose, do it in writing. Request a meeting with HR or occupational health, not just your line manager. Bring documentation: your clinic letter, a statement from your prescribing clinician confirming that your medication does not impair your ability to perform your role, and a clear explanation of when and how you take your medication.
Frame the conversation around your condition and your treatment, not around cannabis. "I have a chronic condition for which I am prescribed medication that may show up on a drug test. I want to ensure the company is aware and that my treatment is accommodated within the drugs policy" is a different conversation from "I use cannabis."
Ask for a written outcome. If your employer agrees to adjust the drugs policy to accommodate your prescription, get it confirmed in writing. If they refuse, you have a record of the refusal — which matters if the situation escalates.
The Bigger Picture
The employment question is a microcosm of the broader tension in UK cannabis policy: the law says one thing, the culture says another, and patients are caught in the gap. Prescribed cannabis is legal. Discrimination against disabled employees is illegal. And yet, patients are losing their jobs over a medication they take legally, for conditions that qualify as disabilities, prescribed by specialist clinicians.
That contradiction will not hold. Employment tribunals, clinical guidelines, and public awareness are all moving in the same direction — slowly, unevenly, but unmistakably. The first major employment case will set a precedent. Until then, patients navigate alone, weighing risks that no employee should have to weigh.
